Anytime ladyparts are in the news, it’s not long before there’s a palpable feeling that longstanding norms of gender equity have been violated and that balance needs to be restored. Often, this just means getting back to the really important stuff, like whether to invade Iran, Syria or both[1]. But there’s also the point that men have parts too, and should have a share in the limelight, the same as women do when we discuss important stuff.[2]
So, I thought I’d talk about a dangly dilemma faced by men of a certain age – whether to take the PSA test for prostate cancer.
These days a lot of authorities recommend against testing. I have ignored their advice, and get tested every couple of years (news good, so far!). So, who is right? And does the argument extend to other parts and tests?
update I thought I’d add a followup question here, rather than in comments. From a decision-theoretic viewpoint, the arguments against testing imply, for consistency, the following further recommendations (subject to some qualifications I’ll spell out).
*First, that someone who takes the test (ignoring the guidelines) and comes up with a high PSA score should not have a biopsy, and should not be tested again.
*Second, that someone who has a biopsy and gets a bad result should just ignore it, and not get tested again.
The qualification is that this treats the cost of the PSA test and the biopsy (which, as discussed in comments, carries some non-trivial risks) as small, relative to the benefits of even modest changes in treatment (such as a shift from complete ignorance to “watchful waiting”). Does anyone know whether these recommendations have in fact been made? If not, can anyone provide a defence of what seems to me to be an obvious inconsistency? End update